Zobrazeno 1 - 10
of 130
pro vyhledávání: '"Eduard, Vrdoljak"'
Autor:
Dora Čerina Pavlinović, Natalija Dedić Plavetić, Ingrid Belac Lovasić, Robert Šeparović, Josipa Flam, Marija Pancirov, Žarko Bajić, Snježana Tomić, Eduard Vrdoljak
Publikováno v:
The Breast Journal, Vol 2024 (2024)
Introduction. Disease recurrence in patients with the early hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) breast tumor subtype is particularly challenging to manage due to its complex and very heterogene
Externí odkaz:
https://doaj.org/article/58fd4feb40884d6bb8fd7ad6d6f40a50
Autor:
Dora Čerina, Tihana Boraska Jelavić, Matea Buljubašić Franić, Krešimir Tomić, Žarko Bajić, Eduard Vrdoljak
Publikováno v:
Current Oncology, Vol 29, Iss 8, Pp 5223-5237 (2022)
Findings on the efficacy of adjuvant chemotherapy (ACT) of locally advanced cervical cancer (LACC) after the concurrent chemoradiation (CCRT) therapy were inconsistent, and the OUTBACK trial was expected to shed some light regarding the topic. Its re
Externí odkaz:
https://doaj.org/article/1e989f4be0fe4c58899844e69ed971e7
Autor:
Marija Ban, Eduard Vrdoljak
Publikováno v:
Libri Oncologici, Vol 50, Iss 2-3, Pp 118-125 (2022)
Breast cancer cells can express HER2 receptors on their membranes to varying degrees. HER2 signalling pathway is important for tumor growth and metastasis. Patients with HER2-positive disease had worse treatment outcomes until the implementation of t
Externí odkaz:
https://doaj.org/article/ff85b223647b48b1a97c6fa386338e15
Publikováno v:
Libri Oncologici, Vol 50, Iss 1, Pp 16-26 (2022)
Aim: To evaluate the treatment outcomes, with emphasis on the efficacy and safety of olaparib, in patients with platinum-sensitive, BRCA-mutated, recurrent ovarian cancer treated at the University Hospital Center Split in the period from June 2016 to
Externí odkaz:
https://doaj.org/article/ab0a578de21d4eadb3470375f60e8b62
Autor:
Ana Fröbe, Blanka Jakšić, Višnja Matković, Herman Haller, Branka Petrić Miše, Dražan Butorac, Goran Vujić, Marina Kos, Tihana Boraska Jelavić, Snježana Tomić, Vanda Paradžik Pašalić, Ante Ćorušić, Ani Mihaljević Ferari, Ivana Canjko, Angela Prgomet Sečan, Danijela Vrdoljak Mozetić, Tanja Leniček, Gordana Lovrenčić-Prpić, Anastazija Aleksandrova Stanojević, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 11-12, Pp 404-415 (2021)
Uterine cancer, according to the latest data from the 2017 Croatian Cancer Registry, is the fourth most common cancer in women in Croatia and ranking eighth in mortality. Most commonly, it is diagnosed in postmenopausal women at the age 50–79. Endo
Externí odkaz:
https://doaj.org/article/f76edb87605b4e399cbea9ffc01535c6
Autor:
Anastazija Aleksandrova Stanojević, Vanda Paradžik Pašalić, Kristina Katić, Herman Haller, Višnja Matković, Goran Vujić, Ani Mihaljević Ferari, Branka Petrić Miše, Tihana Boraska Jelavić, Ana Fröbe, Blanka Jakšić, Ingrid Belac Lovasić, Ante Ćorušić, Deni Karelović, Danijela Vrdoljak Mozetić, Ana Maria Alduk, Ivana Canjko, Snježana Tomić, Senija Eminović, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 11-12, Pp 395-403 (2021)
Cervical cancer, in comparison with other gynecological malignancies, mainly affects younger women. It can be prevented through educational programs, vaccination, screening and early detection. In early stages it can also be effectively treated. Trea
Externí odkaz:
https://doaj.org/article/f1403865587445f69b080f10209e4090
Autor:
Branka Petrić Miše, Višnja Matković, Ingrid Belac Lovasić, Ana Fröbe, Tihana Boraska Jelavić, Kristina Katić, Ivana Canjko, Snježana Tomić, Ante Ćorušić, Damir Babić, Herman Haller, Deni Karelović, Mari Perić, Dinka Šundov, Goran Vujić, Blanka Jakšić, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 143, Iss 11-12, Pp 416-428 (2021)
Ovarian and fallopian tube cancer, i.e., adnexal tumours, and primary peritoneal cancer is the sixth most common female cancer and the deadliest gynecologic tumor in Croatia. Hystologically, these tumors are most commonly of epithelial origin, a sero
Externí odkaz:
https://doaj.org/article/e25d5c9a7f2848b383b82adff66b3704
Autor:
Eduard Vrdoljak, Joseph Gligorov, Lieve Wierinck, PierFranco Conte, Jacques De Grève, Françoise Meunier, Carlo Palmieri, Luzia Travado, Andrew Walker, Theresa Wiseman, Rachel Wuerstlein, Emilio Alba, Concepción Biurrún, Rosanna D’Antona, Oriol Sola-Morales, Catherine Ubaysi, Roberta Ventura, Fatima Cardoso
Publikováno v:
Breast, Vol 55, Iss , Pp 79-90 (2021)
People with metastatic breast cancer face many challenges and disparities in obtaining optimal cancer care. These challenges are accentuated in underserved patient populations across Europe, who are less likely to receive quality healthcare for reaso
Externí odkaz:
https://doaj.org/article/1c3d87f05720487dbcad8a94472a532b
Autor:
Ingrid Belac Lovasić, Martina Bašić Koretić, Paula Podolski, Natalija Dedić Plavetić, Tajana Silovski, Stjepko Pleština, Marijana Jazvić, Željko Soldić, Robert Šeparović, Ana Tečić Vuger, Lidija Beketić Orešković, Ilijan Tomaš, Josipa Flam, Branka Petrić Miše, Marija Ban, Vesna Telesmanić Dobrić, Anuška Budisavljević, Josipa Jović Zlatović, Marijo Nalbani, Željko Vojnović, Zlatko Marušić, Snježana Tomić, Manuela Avirović, Bojan Štambuk, Danko Velimir Vrdoljak, Maja Prutki, Boris Brkljačić, Tade Tadić, Davor Mijatović, Zdenko Stanec, Ivan Milas, Eduard Vrdoljak
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 9-10, Pp 395-305 (2022)
Breast cancer is the most common cancer in women, which can be diagnosed early through screening, early detection and through education. When diagnosed early, it can be successfully treated. Treatment modalities include surgery, chemotherapy, radioth
Externí odkaz:
https://doaj.org/article/8b47de584e464a4896b007bbb6197d58
Autor:
Mark Lawler, Lynne Davies, Simon Oberst, Kathy Oliver, Alexander Eggermont, Anna Schmutz, Carlo La Vecchia, Claudia Allemani, Yolande Lievens, Peter Naredi, Tanja Cufer, Ajay Aggarwal, Matti Aapro, Kathi Apostolidis, Anne-Marie Baird, Fatima Cardoso, Andreas Charalambous, Michel P Coleman, Alberto Costa, Mirjam Crul, Csaba L Dégi, Federica Di Nicolantonio, Sema Erdem, Marius Geanta, Jan Geissler, Jacek Jassem, Beata Jagielska, Bengt Jonsson, Daniel Kelly, Olaf Kelm, Teodora Kolarova, Tezer Kutluk, Grant Lewison, Françoise Meunier, Jana Pelouchova, Thierry Philip, Richard Price, Beate Rau, Isabel T Rubio, Peter Selby, Maja Južnič Sotlar, Gilliosa Spurrier-Bernard, Jolanda C van Hoeve, Eduard Vrdoljak, Willien Westerhuis, Urszula Wojciechowska, Richard Sullivan
Publikováno v:
Lawler, M, Davies, L, Oberst, S, Oliver, K, Eggermont, A, Schmutz, A, La Vecchia, C, Allemani, C, Lievens, Y, Naredi, P, Cufer, T, Aggarwal, A, Aapro, M, Apostolidis, K, Baird, A-M, Cardoso, F, Charalambous, A, Coleman, M P, Costa, A, Crul, M, Dégi, C L, Di Nicolantonio, F, Erdem, S, Geanta, M, Geissler, J, Jassem, J, Jagielska, B, Jonsson, B, Kelly, D, Kelm, O, Kolarova, T, Kutluk, T, Lewison, G, Meunier, F, Pelouchova, J, Philip, T, Price, R, Rau, B, Rubio, I T, Selby, P, Južnič Sotlar, M, Spurrier-Bernard, G, van Hoeve, J C, Vrdoljak, E, Westerhuis, W, Wojciechowska, U & Sullivan, R 2023, ' European Groundshot-addressing Europe's cancer research challenges : a Lancet Oncology Commission ', Lancet Oncology, vol. 24, no. 1, pp. e11-e56 . https://doi.org/10.1016/S1470-2045(22)00540-X
Cancer research is a crucial pillar for countries to deliver more affordable, higher quality, and more equitable cancer care. Patients treated in research-active hospitals have better outcomes than patients who are not treated in these settings. Howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e07d8fcab1f498ebdd71513b8c10c4d
https://doi.org/10.1016/s1470-2045(22)00540-x
https://doi.org/10.1016/s1470-2045(22)00540-x